February 16, 2019

Mingham Ji

Mingham Ji advises pharmaceutical, biotechnology, and medical device clients on a broad range of regulatory, legislative, and compliance issues before FDA and other regulatory agencies. Ms. Ji has particular experience counseling clients on strategic considerations around engagement with and advocacy before FDA, including through formal dispute resolution proceedings, comments to public dockets, and other submissions to the agency. Her work in this area has spanned both drug development and post-approval issues, including pediatric testing requirements and pediatric exclusivity, risk management and pharmacovigilance, data transparency, and manufacturer communications. Ms. Ji also actively participates in Covington’s multidisciplinary Digital Health Initiative and has contributed to the InsideMedicalDevices blog.​​

Articles in the National Law Review database by Mingham Ji

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, February 21, 2019
Tuesday, February 26, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Thursday, February 28, 2019
Wednesday, October 23, 2019